PTH and hypoparathyroidism: The findings indicate that TransCon PTH improved participants’ physical and cognitive hypoparathyroidism symptoms in meaningful ways, while reducing the daily treatment burden, e.g., fewer oral medications needed, associated with conventional therapy for hypoparathyroidism.